As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

Alzheimer’s disease stands as the most widespread form of dementia globally, increasingly burdening families, healthcare ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

South Africa’s government said its HIV-AIDS treatment program is fully funded for the current financial year despite the ...

Scientists have identified a promising new class of treatments for Alzheimer's disease, and they're already widely used to ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful.

Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle claims it used speaker ...